Lenvima 14 MG daily dose 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F13SK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,774
Award facts
- Contract value 100% obligated
- $10,773.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,773.72 by the Defense Logistics Agency on January 23, 2026, for the supply of LENVIMA 14 mg daily dose (60 count). This firm fixed-price, non-set-aside contract is scheduled for completion by February 13, 2026. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
LENVIMA (lenvatinib) is a targeted cancer therapy used in oncology treatment, and this award reflects the Defense Logistics Agency's ongoing pharmaceutical procurement needs to support military treatment facilities and veteran healthcare systems. The delivery order demonstrates AmerisourceBergen's continued capacity to fulfill federal medical supply requirements through open competition, consistent with its extensive portfolio of pharmaceutical product deliveries across multiple therapeutic domains. The company's significant IDC with DLA enables efficient task order execution for essential medications and medical commodities required throughout the Department of Defense healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DR26F13SK?
SPE2DR26F13SK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F13SK worth?
The government has obligated $10,774 on SPE2DR26F13SK.
Is contract SPE2DR26F13SK an order under another contract?
Yes. SPE2DR26F13SK is a delivery order under SPE2DR25D1110, an indefinite delivery contract.
Was contract SPE2DR26F13SK competed?
The extent of competition for SPE2DR26F13SK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award